Spike Protein Mutations in SARS-CoV-2 at Rajasthan, India in December 2020

Introduction: Many mutations have been reported in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) since its first identification. Some are variants of concern (VOC) as they have higher transmission rates. Mutations in the spike protein region are of main concern as they affect transmis...

Full description

Bibliographic Details
Main Author: Swati Gautam; Pratibha Sharma; Himanshu Sharma; Dinesh Parsoya; Farah Deeba; Neha Bhomia; Sudhir Bhandari; Bharti Malhotra
Format: Article
Language:English
Published: Sonali Sharma on behalf of Rajasthan University of Health Sciences 2023-07-01
Series:RUHS Journal of Health Sciences
Subjects:
Introduction: Many mutations have been reported in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) since its first identification. Some are variants of concern (VOC) as they have higher transmission rates. Mutations in the spike protein region are of main concern as they affect transmission rates and can affect efficacy of the vaccines. The objective of present study was to look for spike protein mutations in SARS-CoV-2 using Next Generation Sequencing (NGS) in representative samples received in December 2020 at Rajasthan. Methodology: Ten nasopharyngeal/throat swab specimens from known COVID-19 positive patients were processed for RNA extraction, library preparation, and sequencing was done using specific SARS-CoV-2 Ion-Ampliseq panel by Ion torrent S5 system. Results: Only seven samples gave high quality data. All the isolates belonged to clade GH. We found 11 different mutations in the spike protein region most common were Q1201K, Q677R, D614G, L18F. Some novel mutations were found like S689I, Q23R, D1146E, andM153K. D614G mutation was present in all the samples which are known to promote transmissibility oftheSARS-CoV-2 virus. Conclusion: We did not find any VOC but one sample had N440K mutation which is reported to escape immune response, was found to be prevalent in some other parts of India also, and was considered epidemiologically important at the beginning of second wave. There is a need to carry out sequencing on regular basis to check for emerging mutants and monitor their effect on vaccine efficacy.
Online Access:https://ruhsjhs.in/articleDetails.php?artid=TlRRPQ==
_version_ 1797776135385251840
author Swati Gautam; Pratibha Sharma; Himanshu Sharma; Dinesh Parsoya; Farah Deeba; Neha Bhomia; Sudhir Bhandari; Bharti Malhotra
author_facet Swati Gautam; Pratibha Sharma; Himanshu Sharma; Dinesh Parsoya; Farah Deeba; Neha Bhomia; Sudhir Bhandari; Bharti Malhotra
author_sort Swati Gautam; Pratibha Sharma; Himanshu Sharma; Dinesh Parsoya; Farah Deeba; Neha Bhomia; Sudhir Bhandari; Bharti Malhotra
collection DOAJ
description Introduction: Many mutations have been reported in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) since its first identification. Some are variants of concern (VOC) as they have higher transmission rates. Mutations in the spike protein region are of main concern as they affect transmission rates and can affect efficacy of the vaccines. The objective of present study was to look for spike protein mutations in SARS-CoV-2 using Next Generation Sequencing (NGS) in representative samples received in December 2020 at Rajasthan. Methodology: Ten nasopharyngeal/throat swab specimens from known COVID-19 positive patients were processed for RNA extraction, library preparation, and sequencing was done using specific SARS-CoV-2 Ion-Ampliseq panel by Ion torrent S5 system. Results: Only seven samples gave high quality data. All the isolates belonged to clade GH. We found 11 different mutations in the spike protein region most common were Q1201K, Q677R, D614G, L18F. Some novel mutations were found like S689I, Q23R, D1146E, andM153K. D614G mutation was present in all the samples which are known to promote transmissibility oftheSARS-CoV-2 virus. Conclusion: We did not find any VOC but one sample had N440K mutation which is reported to escape immune response, was found to be prevalent in some other parts of India also, and was considered epidemiologically important at the beginning of second wave. There is a need to carry out sequencing on regular basis to check for emerging mutants and monitor their effect on vaccine efficacy.
first_indexed 2024-03-12T22:46:35Z
format Article
id doaj.art-d9283cd3f93840e8baa60e5f38167d0f
institution Directory Open Access Journal
issn 2456-8309
2582-3590
language English
last_indexed 2024-03-12T22:46:35Z
publishDate 2023-07-01
publisher Sonali Sharma on behalf of Rajasthan University of Health Sciences
record_format Article
series RUHS Journal of Health Sciences
spelling doaj.art-d9283cd3f93840e8baa60e5f38167d0f2023-07-21T05:43:55ZengSonali Sharma on behalf of Rajasthan University of Health SciencesRUHS Journal of Health Sciences2456-83092582-35902023-07-01http://dx.doi.org/10.37821/ruhsjhs.7.1.2022.419Spike Protein Mutations in SARS-CoV-2 at Rajasthan, India in December 2020Swati Gautam; Pratibha Sharma; Himanshu Sharma; Dinesh Parsoya; Farah Deeba; Neha Bhomia; Sudhir Bhandari; Bharti Malhotra0Research Scientist-B, Research Scientist; Research Assistant; Senior Professor and Head, Department of Microbiology, Principal and Controller, SMS Medical College and Associated Group of Hospitals, Jaipur, Rajasthan, IndiaIntroduction: Many mutations have been reported in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) since its first identification. Some are variants of concern (VOC) as they have higher transmission rates. Mutations in the spike protein region are of main concern as they affect transmission rates and can affect efficacy of the vaccines. The objective of present study was to look for spike protein mutations in SARS-CoV-2 using Next Generation Sequencing (NGS) in representative samples received in December 2020 at Rajasthan. Methodology: Ten nasopharyngeal/throat swab specimens from known COVID-19 positive patients were processed for RNA extraction, library preparation, and sequencing was done using specific SARS-CoV-2 Ion-Ampliseq panel by Ion torrent S5 system. Results: Only seven samples gave high quality data. All the isolates belonged to clade GH. We found 11 different mutations in the spike protein region most common were Q1201K, Q677R, D614G, L18F. Some novel mutations were found like S689I, Q23R, D1146E, andM153K. D614G mutation was present in all the samples which are known to promote transmissibility oftheSARS-CoV-2 virus. Conclusion: We did not find any VOC but one sample had N440K mutation which is reported to escape immune response, was found to be prevalent in some other parts of India also, and was considered epidemiologically important at the beginning of second wave. There is a need to carry out sequencing on regular basis to check for emerging mutants and monitor their effect on vaccine efficacy.https://ruhsjhs.in/articleDetails.php?artid=TlRRPQ==Introduction: Many mutations have been reported in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) since its first identification. Some are variants of concern (VOC) as they have higher transmission rates. Mutations in the spike protein region are of main concern as they affect transmission rates and can affect efficacy of the vaccines. The objective of present study was to look for spike protein mutations in SARS-CoV-2 using Next Generation Sequencing (NGS) in representative samples received in December 2020 at Rajasthan. Methodology: Ten nasopharyngeal/throat swab specimens from known COVID-19 positive patients were processed for RNA extraction, library preparation, and sequencing was done using specific SARS-CoV-2 Ion-Ampliseq panel by Ion torrent S5 system. Results: Only seven samples gave high quality data. All the isolates belonged to clade GH. We found 11 different mutations in the spike protein region most common were Q1201K, Q677R, D614G, L18F. Some novel mutations were found like S689I, Q23R, D1146E, andM153K. D614G mutation was present in all the samples which are known to promote transmissibility oftheSARS-CoV-2 virus. Conclusion: We did not find any VOC but one sample had N440K mutation which is reported to escape immune response, was found to be prevalent in some other parts of India also, and was considered epidemiologically important at the beginning of second wave. There is a need to carry out sequencing on regular basis to check for emerging mutants and monitor their effect on vaccine efficacy.
spellingShingle Swati Gautam; Pratibha Sharma; Himanshu Sharma; Dinesh Parsoya; Farah Deeba; Neha Bhomia; Sudhir Bhandari; Bharti Malhotra
Spike Protein Mutations in SARS-CoV-2 at Rajasthan, India in December 2020
RUHS Journal of Health Sciences
Introduction: Many mutations have been reported in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) since its first identification. Some are variants of concern (VOC) as they have higher transmission rates. Mutations in the spike protein region are of main concern as they affect transmission rates and can affect efficacy of the vaccines. The objective of present study was to look for spike protein mutations in SARS-CoV-2 using Next Generation Sequencing (NGS) in representative samples received in December 2020 at Rajasthan. Methodology: Ten nasopharyngeal/throat swab specimens from known COVID-19 positive patients were processed for RNA extraction, library preparation, and sequencing was done using specific SARS-CoV-2 Ion-Ampliseq panel by Ion torrent S5 system. Results: Only seven samples gave high quality data. All the isolates belonged to clade GH. We found 11 different mutations in the spike protein region most common were Q1201K, Q677R, D614G, L18F. Some novel mutations were found like S689I, Q23R, D1146E, andM153K. D614G mutation was present in all the samples which are known to promote transmissibility oftheSARS-CoV-2 virus. Conclusion: We did not find any VOC but one sample had N440K mutation which is reported to escape immune response, was found to be prevalent in some other parts of India also, and was considered epidemiologically important at the beginning of second wave. There is a need to carry out sequencing on regular basis to check for emerging mutants and monitor their effect on vaccine efficacy.
title Spike Protein Mutations in SARS-CoV-2 at Rajasthan, India in December 2020
title_full Spike Protein Mutations in SARS-CoV-2 at Rajasthan, India in December 2020
title_fullStr Spike Protein Mutations in SARS-CoV-2 at Rajasthan, India in December 2020
title_full_unstemmed Spike Protein Mutations in SARS-CoV-2 at Rajasthan, India in December 2020
title_short Spike Protein Mutations in SARS-CoV-2 at Rajasthan, India in December 2020
title_sort spike protein mutations in sars cov 2 at rajasthan india in december 2020
topic Introduction: Many mutations have been reported in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) since its first identification. Some are variants of concern (VOC) as they have higher transmission rates. Mutations in the spike protein region are of main concern as they affect transmission rates and can affect efficacy of the vaccines. The objective of present study was to look for spike protein mutations in SARS-CoV-2 using Next Generation Sequencing (NGS) in representative samples received in December 2020 at Rajasthan. Methodology: Ten nasopharyngeal/throat swab specimens from known COVID-19 positive patients were processed for RNA extraction, library preparation, and sequencing was done using specific SARS-CoV-2 Ion-Ampliseq panel by Ion torrent S5 system. Results: Only seven samples gave high quality data. All the isolates belonged to clade GH. We found 11 different mutations in the spike protein region most common were Q1201K, Q677R, D614G, L18F. Some novel mutations were found like S689I, Q23R, D1146E, andM153K. D614G mutation was present in all the samples which are known to promote transmissibility oftheSARS-CoV-2 virus. Conclusion: We did not find any VOC but one sample had N440K mutation which is reported to escape immune response, was found to be prevalent in some other parts of India also, and was considered epidemiologically important at the beginning of second wave. There is a need to carry out sequencing on regular basis to check for emerging mutants and monitor their effect on vaccine efficacy.
url https://ruhsjhs.in/articleDetails.php?artid=TlRRPQ==
work_keys_str_mv AT swatigautampratibhasharmahimanshusharmadineshparsoyafarahdeebanehabhomiasudhirbhandaribhartimalhotra spikeproteinmutationsinsarscov2atrajasthanindiaindecember2020